Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Saiyed Atiq Raza sold 41,439 shares of the stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $10.37, for a total value of $429,722.43. Following the transaction, the director now directly owns 690,121 shares in the company, valued at $7,156,554.77. The trade was a 5.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Saiyed Atiq Raza also recently made the following trade(s):
- On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The stock was sold at an average price of $10.07, for a total transaction of $122,511.62.
- On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $24,024.00.
Arteris Trading Up 0.8 %
Shares of AIP stock traded up $0.08 on Monday, reaching $10.35. 261,787 shares of the company’s stock were exchanged, compared to its average volume of 169,906. The company’s fifty day simple moving average is $8.50 and its 200 day simple moving average is $7.95. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $10.69. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $415.83 million, a PE ratio of -10.78 and a beta of 1.25.
Analyst Upgrades and Downgrades
Institutional Investors Weigh In On Arteris
Hedge funds have recently made changes to their positions in the company. US Bancorp DE purchased a new stake in Arteris during the third quarter valued at approximately $34,000. The Manufacturers Life Insurance Company acquired a new stake in Arteris during the 2nd quarter valued at approximately $86,000. Algert Global LLC acquired a new stake in Arteris during the 2nd quarter worth about $115,000. MetLife Investment Management LLC raised its position in Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after acquiring an additional 9,551 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Arteris during the 3rd quarter valued at about $226,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Election Stocks: How Elections Affect the Stock Market
- Micron: Why Now Is the Time to Be Brave
- Transportation Stocks Investing
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.